View Financial HealthUltralife 配当と自社株買い配当金 基準チェック /06Ultralife配当金を支払った記録がありません。主要情報n/a配当利回り-0.09%バイバック利回り総株主利回り-0.09%将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向n/a最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesお知らせ • May 02Ultralife Corporation to Report Q1, 2026 Results on May 08, 2026Ultralife Corporation announced that they will report Q1, 2026 results at 9:30 AM, US Eastern Standard Time on May 08, 2026お知らせ • Mar 18Ultralife Corporation announced delayed annual 10-K filingOn 03/17/2026, Ultralife Corporation announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Mar 10Ultralife Corporation Reports Unaudited Impairment Results for the Fourth Quarter Ended December 31, 2025Ultralife Corporation reported unaudited impairment results for the fourth quarter ended December 31, 2025. For the period, the company reported intangible asset impairment of $12,181,000. In the quarter of 2025, the company decided to undergo a comprehensive rebranding initiative that consolidated all sub-brands under a singular, unified master brand – Ultralife. To this end, the Accutronics, Southwest Electronic Energy, Excell Battery, McDowell Research and AMTI brands will no longer be used. The Electrochem brand will remain in use, but as a product brand on select primary cells. As a result of the rebranding initiative, the company recorded a $12.2 million non-cash charge to reduce the value of the company’s tradename and trademark intangible assets.お知らせ • Mar 06Ultralife Corporation to Report Q4, 2025 Results on Mar 10, 2026Ultralife Corporation announced that they will report Q4, 2025 results Pre-Market on Mar 10, 2026お知らせ • Nov 14Ultralife Corporation to Report Q3, 2025 Results on Nov 18, 2025Ultralife Corporation announced that they will report Q3, 2025 results at 9:30 AM, US Eastern Standard Time on Nov 18, 2025お知らせ • Nov 08Ultralife Corporation announced delayed 10-Q filingOn 11/07/2025, Ultralife Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.分析記事 • Aug 17Ultralife Corporation's (NASDAQ:ULBI) Share Price Is Still Matching Investor Opinion Despite 25% SlumpNasdaqGM:ULBI 1 Year Share Price vs Fair Value Explore Ultralife's Fair Values from the Community and select yours The...お知らせ • Jul 29Ultralife Corporation to Report Q2, 2025 Results on Aug 07, 2025Ultralife Corporation announced that they will report Q2, 2025 results Pre-Market on Aug 07, 2025分析記事 • Jul 02Ultralife (NASDAQ:ULBI) Has A Somewhat Strained Balance SheetHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...お知らせ • Jun 30+ 18 more updatesUltralife Corporation(NasdaqGM:ULBI) dropped from Russell 2000 Growth-Defensive IndexUltralife Corporation(NasdaqGM:ULBI) dropped from Russell 2000 Growth-Defensive IndexSeeking Alpha • Jun 30Ultralife: Recharging Growth With Smart AcquisitionsSummary Ultralife's revenue has been volatile in the past decade or so, but its recent comeback seems to have more legroom to grow. Through a series of recent acquisitions, the company has diversified its revenue dependence on government contracts and obtained access to a more domestic and overseas customer base. Key financial metrics demonstrate strong cash flow and organic integration of its acquisitions, supporting a positive outlook. Intense competition in the industry and integration risk remain, but so far the results show positive impacts in sales and cash flow. In conclusion, ULBI's current price is relatively cheap for interested investors seeking exposure in this field. Read the full article on Seeking Alphaお知らせ • May 29Ultralife Corporation, Annual General Meeting, Jul 16, 2025Ultralife Corporation, Annual General Meeting, Jul 16, 2025. Location: atlanta airport marriott gateway, 2020 convention center concourse, ga 30337, atlanta United Statesお知らせ • Apr 29Ultralife Corporation to Report Q1, 2025 Results on May 09, 2025Ultralife Corporation announced that they will report Q1, 2025 results Pre-Market on May 09, 2025お知らせ • Mar 09Ultralife Corporation announced delayed annual 10-K filingOn 03/07/2025, Ultralife Corporation announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Feb 26Ultralife Corporation to Report Q4, 2024 Results on Mar 11, 2025Ultralife Corporation announced that they will report Q4, 2024 results Pre-Market on Mar 11, 2025Seeking Alpha • Jan 22Ultralife Corporation: A High-Risk Stock With Just Enough Upside To HoldSummary Ultralife Corporation is an industrial player with a global presence, specializing in power solutions and communication systems. The company reported a nearly 10% YoY revenue decline in Q3, with contracting profit margins and significant supply chain issues. While Ultralife has a solid balance sheet and liquidity, its thin profit margins and supply chain vulnerabilities raise concerns about long-term shareholder value. Despite its fair valuation, the stock is considered a high-risk play due to weak revenue predictability and operational inefficiencies. The overall recommendation for ULBI is a "hold" rating, as growth prospects exist, but risks outweigh immediate investment opportunities. Read the full article on Seeking Alphaお知らせ • Jan 06Ultralife Corporation Announces the Appointment of Jeffrey Luke as Chief Marketing Officer and James Pope as Senior Vice President - Sales & Business Development, Battery & Energy Products, Effective January 6, 2025Ultralife Corporation announced the appointment of Jeffrey Luke as Chief Marketing Officer and James Pope as Senior Vice President - Sales & Business Development, Battery & Energy Products, effective January 6, 2025. As Chief Marketing Officer, Jeff will be responsible for reframing corporate and brand strategies, providing alignment and accountability throughout the global organization. He will collaborate closely with sales and engineering teams to develop and execute effective go-to-market strategies, ensuring that Ultralife’s products and solutions meet the evolving needs of customers. Jeff brings over two decades of experience in B2B marketing, including genomics, agriculture, heavy equipment, energy and industrial computing. In his new role, James will focus on expanding reach into both existing and new markets and applications, and on aligning the efforts of global sales and business development teams in pursuing opportunities that maximize revenue, build strategic partnerships, and strengthen presence in competitive markets. He brings over thirty-seven years of experience in the battery and power industry, with a career that spans all major segments of the industry, including cell manufacturing, pack manufacturing, charger development, and work with representative organizations supporting battery and power solutions.新しいナラティブ • Nov 10Lean Productivity And Tactical Acquisitions Propel Future Growth Amid Industry Challenges Ultralife's focus on cost reduction and productivity improvements is expected to boost net margins significantly. お知らせ • Oct 24Ultralife Corporation to Report Q3, 2024 Results on Nov 08, 2024Ultralife Corporation announced that they will report Q3, 2024 results Pre-Market on Nov 08, 2024お知らせ • Oct 01Ultralife Corporation (NasdaqGM:ULBI) signed a stock purchase agreement to acquire Electrochem Solutions, Inc. from Integer Holdings Corporation (NYSE:ITGR) for $50 million.Ultralife Corporation (NasdaqGM:ULBI) signed a stock purchase agreement to acquire Electrochem Solutions, Inc. from Integer Holdings Corporation (NYSE:ITGR) for $50 million on September 30, 2024. A cash consideration of $50 million will be paid by Ultralife Corporation. As part of consideration, $50 million is paid towards common equity of Electrochem Solutions, Inc. Ultralife expects to finance the transaction through its primary lender. The expected completion of the transaction is by the end of October 2024.分析記事 • Sep 07Should You Think About Buying Ultralife Corporation (NASDAQ:ULBI) Now?While Ultralife Corporation ( NASDAQ:ULBI ) might not have the largest market cap around , it saw significant share...Seeking Alpha • Aug 03Ultralife: I Bought The Dip; Here Comes The GrowthSummary ULBI's share price fell to $7 following a cyber-attack, but has since recovered to $11.50, making a 50% return in 6 months. ULBI's growth in sales revenue is driven by its battery and energy products segment, with a focus on lithium-ion batteries and communication systems. The company's adoption of lean manufacturing techniques, margin improvement, and debt paydown have led to a significant increase in performance and future cash generation, warranting a Strong Buy recommendation with a price target of $35. Read the full article on Seeking Alpha分析記事 • Aug 01Ultralife's (NASDAQ:ULBI) Earnings Are Weaker Than They SeemDespite announcing strong earnings, Ultralife Corporation's ( NASDAQ:ULBI ) stock was sluggish. We think that the...お知らせ • Jul 12Ultralife Corporation to Report Q2, 2024 Results on Jul 25, 2024Ultralife Corporation announced that they will report Q2, 2024 results Pre-Market on Jul 25, 2024Seeking Alpha • Jun 30Ultralife Corporation Is Attractive HereSummary Ultralife Corporation specializes in batteries for government, military, and private sectors, with a focus on communications systems. Recent growth initiatives include new product developments like EL8000 Case Systems and Thin Cell Batteries. The company has shown strong revenue growth, successful M&A track record, gross margin expansion, and stable operating expenses, making it a promising investment. Read the full article on Seeking Alphaお知らせ • May 31Ultralife Corporation, Annual General Meeting, Jul 16, 2024Ultralife Corporation, Annual General Meeting, Jul 16, 2024. Location: eastern time at the sheraton charlotte, airport hotel located at 3315, scott futrell drive, nc 28202, charlotte United StatesValuation Update With 7 Day Price Move • May 03Investor sentiment improves as stock rises 17%After last week's 17% share price gain to US$12.56, the stock trades at a trailing P/E ratio of 19.8x. Average trailing P/E is 20x in the Electrical industry in the US. Total returns to shareholders of 60% over the past three years.Price Target Changed • Apr 28Price target decreased by 7.7% to US$12.00Down from US$13.00, the current price target is provided by 1 analyst. New target price is 5.4% above last closing price of US$11.39. Stock is up 171% over the past year. The company is forecast to post earnings per share of US$0.61 for next year compared to US$0.44 last year.Reported Earnings • Apr 26First quarter 2024 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2024 results: EPS: US$0.18 (up from US$0.021 loss in 1Q 2023). Revenue: US$41.9m (up 31% from 1Q 2023). Net income: US$2.89m (up US$3.24m from 1Q 2023). Profit margin: 6.9% (up from net loss in 1Q 2023). The move to profitability was driven by higher revenue. Revenue exceeded analyst estimates by 10%. Earnings per share (EPS) also surpassed analyst estimates by 100%. Over the last 3 years on average, earnings per share has increased by 45% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth.Seeking Alpha • Apr 22Ultralife Corporation: Ready To SurgeSummary ULBI is likely to deliver above-market returns in the next two years, with improving fundamentals and a modest valuation. They should benefit from growth in the battery market and increased military spending. Management is delivering on growth and margin improvement; EPS could double in 2024. With a strengthened balance sheet, they seem poised to start deleveraging rapidly. Read the full article on Seeking Alpha分析記事 • Apr 16These 4 Measures Indicate That Ultralife (NASDAQ:ULBI) Is Using Debt Reasonably WellThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...お知らせ • Apr 12Ultralife Corporation to Report Q1, 2024 Results on Apr 25, 2024Ultralife Corporation announced that they will report Q1, 2024 results Pre-Market on Apr 25, 2024Reported Earnings • Mar 23Full year 2023 earnings released: EPS: US$0.44 (vs US$0.007 loss in FY 2022)Full year 2023 results: EPS: US$0.44 (up from US$0.007 loss in FY 2022). Revenue: US$158.6m (up 20% from FY 2022). Net income: US$7.20m (up US$7.32m from FY 2022). Profit margin: 4.5% (up from net loss in FY 2022). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.分析記事 • Mar 14Slowing Rates Of Return At Ultralife (NASDAQ:ULBI) Leave Little Room For ExcitementIf we want to find a potential multi-bagger, often there are underlying trends that can provide clues. One common...Reported Earnings • Feb 18Full year 2023 earnings released: EPS: US$0.44 (vs US$0.007 loss in FY 2022)Full year 2023 results: EPS: US$0.44 (up from US$0.007 loss in FY 2022). Revenue: US$158.6m (up 20% from FY 2022). Net income: US$7.20m (up US$7.32m from FY 2022). Profit margin: 4.5% (up from net loss in FY 2022). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Feb 15Investor sentiment improves as stock rises 15%After last week's 15% share price gain to US$7.90, the stock trades at a trailing P/E ratio of 31.5x. Average trailing P/E is 19x in the Electrical industry in the US. Total returns to shareholders of 7.5% over the past three years.分析記事 • Feb 11Insufficient Growth At Ultralife Corporation (NASDAQ:ULBI) Hampers Share PriceWith a price-to-sales (or "P/S") ratio of 0.9x Ultralife Corporation ( NASDAQ:ULBI ) may be sending bullish signals at...New Risk • Feb 09New major risk - Revenue and earnings growthEarnings have declined by 59% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. This is currently the only risk that has been identified for the company.お知らせ • Jan 30Ultralife Corporation to Report Q4, 2023 Results on Feb 15, 2024Ultralife Corporation announced that they will report Q4, 2023 results Pre-Market on Feb 15, 2024Recent Insider Transactions • Dec 11Independent Chairman recently bought US$111k worth of stockOn the 8th of December, Bradford Whitmore bought around 16k shares on-market at roughly US$6.99 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger purchase worth US$181k. Bradford has been a buyer over the last 12 months, purchasing a net total of US$1.5m worth in shares.Recent Insider Transactions • Dec 01Independent Chairman recently bought US$181k worth of stockOn the 29th of November, Bradford Whitmore bought around 25k shares on-market at roughly US$7.20 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Bradford has been a buyer over the last 12 months, purchasing a net total of US$1.6m worth in shares.Recent Insider Transactions • Nov 03Independent Chairman recently bought US$99k worth of stockOn the 1st of November, Bradford Whitmore bought around 14k shares on-market at roughly US$7.14 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger purchase worth US$112k. Bradford has been a buyer over the last 12 months, purchasing a net total of US$1.5m worth in shares.Valuation Update With 7 Day Price Move • Nov 02Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to US$7.44, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 17x in the Electrical industry in the US. Total returns to shareholders of 45% over the past three years.Reported Earnings • Oct 26Third quarter 2023 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2023 results: EPS: US$0.082 (up from US$0.015 loss in 3Q 2022). Revenue: US$39.5m (up 19% from 3Q 2022). Net income: US$1.33m (up US$1.57m from 3Q 2022). Profit margin: 3.4% (up from net loss in 3Q 2022). The move to profitability was driven by higher revenue. Revenue is forecast to grow 9.9% p.a. on average during the next 2 years, compared to a 6.6% growth forecast for the Electrical industry in the US. Over the last 3 years on average, earnings per share has fallen by 53% per year but the company’s share price has increased by 12% per year, which means it is well ahead of earnings.分析記事 • Oct 26Is Now An Opportune Moment To Examine Ultralife Corporation (NASDAQ:ULBI)?While Ultralife Corporation ( NASDAQ:ULBI ) might not be the most widely known stock at the moment, it led the NASDAQGM...お知らせ • Oct 13Ultralife Corporation to Report Q3, 2023 Results on Oct 26, 2023Ultralife Corporation announced that they will report Q3, 2023 results Pre-Market on Oct 26, 2023Valuation Update With 7 Day Price Move • Oct 02Investor sentiment improves as stock rises 18%After last week's 18% share price gain to US$11.37, the stock trades at a forward P/E ratio of 24x. Average forward P/E is 21x in the Electrical industry in the US. Total returns to shareholders of 88% over the past three years.分析記事 • Sep 22Ultralife (NASDAQ:ULBI) May Have Issues Allocating Its CapitalIf you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Recent Insider Transactions • Sep 18Independent Chairman recently bought US$112k worth of stockOn the 15th of September, Bradford Whitmore bought around 11k shares on-market at roughly US$10.15 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Bradford has been a buyer over the last 12 months, purchasing a net total of US$1.4m worth in shares.Valuation Update With 7 Day Price Move • Aug 22Investor sentiment improves as stock rises 27%After last week's 27% share price gain to US$10.43, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 20x in the Electrical industry in the US. Total returns to shareholders of 64% over the past three years.Major Estimate Revision • Aug 09Consensus revenue estimates increase by 12%The consensus outlook for revenues in fiscal year 2023 has improved. 2023 revenue forecast increased from US$136.8m to US$153.1m. EPS estimate increased from US$0.21 to US$0.35 per share. Net income forecast to grow 196% next year vs 16% growth forecast for Electrical industry in the US. Consensus price target of US$12.00 unchanged from last update. Share price was steady at US$8.54 over the past week.New Risk • Jul 29New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of American stocks, typically moving 16% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. This is currently the only risk that has been identified for the company.Reported Earnings • Jul 28Second quarter 2023 earnings: EPS and revenues exceed analyst expectationsSecond quarter 2023 results: EPS: US$0.21 (up from US$0.032 in 2Q 2022). Revenue: US$42.7m (up 33% from 2Q 2022). Net income: US$3.34m (up US$2.83m from 2Q 2022). Profit margin: 7.8% (up from 1.6% in 2Q 2022). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 33%. Earnings per share (EPS) also surpassed analyst estimates. Revenue is forecast to grow 3.2% p.a. on average during the next 2 years, compared to a 9.0% growth forecast for the Electrical industry in the US. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 84 percentage points per year, which is a significant difference in performance.お知らせ • Jul 14Ultralife Corporation to Report Q2, 2023 Results on Jul 27, 2023Ultralife Corporation announced that they will report Q2, 2023 results Pre-Market on Jul 27, 2023Recent Insider Transactions • Jun 18Independent Chairman recently bought US$398k worth of stockOn the 14th of June, Bradford Whitmore bought around 81k shares on-market at roughly US$4.94 per share. This transaction amounted to 1.5% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Bradford has been a buyer over the last 12 months, purchasing a net total of US$1.9m worth in shares.分析記事 • Jun 08Ultralife (NASDAQ:ULBI) Takes On Some Risk With Its Use Of DebtThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Recent Insider Transactions • Jun 04Independent Chairman recently bought US$146k worth of stockOn the 1st of June, Bradford Whitmore bought around 34k shares on-market at roughly US$4.31 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Bradford has been a buyer over the last 12 months, purchasing a net total of US$1.7m worth in shares.お知らせ • May 31Ultralife Corporation, Annual General Meeting, Jul 19, 2023Ultralife Corporation, Annual General Meeting, Jul 19, 2023, at 09:00 US Eastern Standard Time. Location: Ultralife Corporation Headquarters located at 2000 Technology Parkway, Newark New York United States Agenda: To consider Election of directors; to consider ratification of the selection of Freed Maxick CPAs, P.C. as company's independent registered public accounting firm for the fiscal year ending December 31, 2023; to consider and vote on a non-binding advisory resolution on executive compensation; to vote on a non-binding advisory resolution on the frequency of future advisory votes on executive compensation; and to consider other matters.Recent Insider Transactions • May 14Independent Chairman recently bought US$117k worth of stockOn the 11th of May, Bradford Whitmore bought around 29k shares on-market at roughly US$4.06 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger purchase worth US$122k. Bradford has been a buyer over the last 12 months, purchasing a net total of US$1.5m worth in shares.Reported Earnings • Apr 06Full year 2022 earnings released: US$0.007 loss per share (vs US$0.015 loss in FY 2021)Full year 2022 results: US$0.007 loss per share (improved from US$0.015 loss in FY 2021). Revenue: US$131.8m (up 34% from FY 2021). Net loss: US$119.0k (loss narrowed 49% from FY 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 68 percentage points per year, which is a significant difference in performance.Recent Insider Transactions • Mar 19Independent Chairman recently bought US$122k worth of stockOn the 13th of March, Bradford Whitmore bought around 30k shares on-market at roughly US$4.06 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Bradford has been a buyer over the last 12 months, purchasing a net total of US$1.4m worth in shares.Reported Earnings • Mar 03Full year 2022 earnings released: US$0.007 loss per share (vs US$0.015 loss in FY 2021)Full year 2022 results: US$0.007 loss per share (improved from US$0.015 loss in FY 2021). Revenue: US$131.8m (up 34% from FY 2021). Net loss: US$119.0k (loss narrowed 49% from FY 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 67 percentage points per year, which is a significant difference in performance.Recent Insider Transactions • Dec 12Independent Chairman recently bought US$279k worth of stockOn the 8th of December, Bradford Whitmore bought around 69k shares on-market at roughly US$4.03 per share. This transaction amounted to 1.3% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Bradford has been a buyer over the last 12 months, purchasing a net total of US$1.7m worth in shares.Price Target Changed • Nov 17Price target increased to US$12.00Up from US$4.50, the current price target is provided by 1 analyst. New target price is 158% above last closing price of US$4.66. Stock is down 23% over the past year. The company is forecast to post earnings per share of US$0.17 next year compared to a net loss per share of US$0.015 last year.Board Change • Nov 17Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. No experienced directors. 5 highly experienced directors. CEO, President & Director Mike Popielec was the last director to join the board, commencing their role in 2010. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Oct 27Third quarter 2022 earnings: EPS misses analyst expectationsThird quarter 2022 results: US$0.015 loss per share (improved from US$0.036 loss in 3Q 2021). Revenue: US$33.2m (up 53% from 3Q 2021). Net loss: US$239.0k (loss narrowed 59% from 3Q 2021). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates. Revenue is forecast to grow 8.4% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Electrical industry in the US. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 81 percentage points per year, which is a significant difference in performance.分析記事 • Sep 27Ultralife (NASDAQ:ULBI) Is Carrying A Fair Bit Of DebtSome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Seeking Alpha • Sep 22Ultralife secures $7.5M communications systems contractUltralife (NASDAQ:ULBI) announced Thursday it has received $7.5M contract to supply its integrated system of A-320 amplifiers and A-320HVA radio vehicle mounts to a major international defense contractor for government/defense modernization program. Deliveries are expected to commence in the fourth quarter of 2022 and continue through the first half of 2023. “This contract further demonstrates our success in executing a key element of our revenue growth strategy – the broadening of our global presence with international allies by extending our core U.S. government and defense business,” said Michael D. Popielec, Ultralife’s President and Chief Executive Officer.Recent Insider Transactions • Aug 21Independent Chairman recently bought US$158k worth of stockOn the 18th of August, Bradford Whitmore bought around 34k shares on-market at roughly US$4.62 per share. In the last 3 months, they made an even bigger purchase worth US$467k. Bradford has been a buyer over the last 12 months, purchasing a net total of US$1.4m worth in shares.Recent Insider Transactions • Aug 06Independent Chairman recently bought US$467k worth of stockOn the 4th of August, Bradford Whitmore bought around 100k shares on-market at roughly US$4.67 per share. This was the largest purchase by an insider in the last 3 months. Bradford has been a buyer over the last 12 months, purchasing a net total of US$1.2m worth in shares.Reported Earnings • Jul 28Second quarter 2022 earnings: EPS and revenues exceed analyst expectationsSecond quarter 2022 results: EPS: US$0.032 (down from US$0.051 in 2Q 2021). Revenue: US$32.1m (up 20% from 2Q 2021). Net income: US$512.0k (down 37% from 2Q 2021). Profit margin: 1.6% (down from 3.0% in 2Q 2021). Revenue exceeded analyst estimates by 2.0%. Earnings per share (EPS) also surpassed analyst estimates by 200%. Over the next year, revenue is forecast to grow 24%, compared to a 26% growth forecast for the industry in the US. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 77 percentage points per year, which is a significant difference in performance.Seeking Alpha • Jul 26Ultralife receives $4.6M communications systems VAA orderUltralife (NASDAQ:ULBI) received a purchase order worth ~$4.6M for supplying its Vehicle Amplifier-Adaptors (VAA) to a global prime defense contractor. Ultralife’s VAA platform provides the soldier with an enhanced range of digital voice and data communications and operational flexibility. Shipments are expected to commence in 2022.Recent Insider Transactions • Jun 11Independent Chairman recently bought US$219k worth of stockOn the 8th of June, Bradford Whitmore bought around 43k shares on-market at roughly US$5.10 per share. This was the largest purchase by an insider in the last 3 months. Bradford has been a buyer over the last 12 months, purchasing a net total of US$960k worth in shares.Reported Earnings • Apr 29First quarter 2022 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2022 results: US$0.01 loss per share (down from US$0.042 profit in 1Q 2021). Revenue: US$30.4m (up 17% from 1Q 2021). Net loss: US$168.0k (down 125% from profit in 1Q 2021). Revenue exceeded analyst estimates by 19%. Earnings per share (EPS) also surpassed analyst estimates by 83%. Over the next year, revenue is forecast to grow 24%, compared to a 18% growth forecast for the industry in the US. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 74 percentage points per year, which is a significant difference in performance.Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. No experienced directors. 5 highly experienced directors. CEO, President & Director Mike Popielec was the last director to join the board, commencing their role in 2010. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.分析記事 • Apr 15Does Ultralife (NASDAQ:ULBI) Have A Healthy Balance Sheet?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Reported Earnings • Mar 11Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2021 results: US$0.015 loss per share (down from US$0.33 profit in FY 2020). Revenue: US$98.3m (down 8.8% from FY 2020). Net loss: US$234.0k (down 105% from profit in FY 2020). Revenue exceeded analyst estimates by 3.4%. Earnings per share (EPS) missed analyst estimates. Over the next year, revenue is forecast to grow 26%, compared to a 21% growth forecast for the industry in the US. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 66 percentage points per year, which is a significant difference in performance.Recent Insider Transactions • Mar 06Independent Chairman recently bought US$245k worth of stockOn the 28th of February, Bradford Whitmore bought around 55k shares on-market at roughly US$4.45 per share. In the last 3 months, they made an even bigger purchase worth US$297k. Bradford has been a buyer over the last 12 months, purchasing a net total of US$741k worth in shares.Reported Earnings • Feb 05Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2021 results: US$0.015 loss per share (down from US$0.33 profit in FY 2020). Revenue: US$98.3m (down 8.8% from FY 2020). Net loss: US$234.0k (down 105% from profit in FY 2020). Revenue exceeded analyst estimates by 3.4%. Earnings per share (EPS) missed analyst estimates. Over the next year, revenue is forecast to grow 17%, compared to a 117% growth forecast for the industry in the US. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 67 percentage points per year, which is a significant difference in performance.Major Estimate Revision • Dec 22Consensus revenue estimates fall by 14%The consensus outlook for revenues in 2021 has deteriorated. 2021 revenue forecast decreased from US$110.7m to US$95.0m. EPS estimate fell from US$0.31 to US$0.02 per share. Net income forecast to grow 134% next year vs 18% growth forecast for Electrical industry in the US. Consensus price target of US$12.00 unchanged from last update. Share price rose 14% to US$6.06 over the past week.Valuation Update With 7 Day Price Move • Dec 18Investor sentiment improved over the past weekAfter last week's 16% share price gain to US$6.05, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 21x in the Electrical industry in the US. Total loss to shareholders of 6.9% over the past three years.決済の安定と成長配当データの取得安定した配当: ULBIの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: ULBIの配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場Ultralife 配当利回り対市場ULBI 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (ULBI)n/a市場下位25% (US)1.4%市場トップ25% (US)4.2%業界平均 (Electrical)0.6%アナリスト予想 (ULBI) (最長3年)n/a注目すべき配当: ULBIは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: ULBIは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: ULBIの 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。株主配当金キャッシュフローカバレッジ: ULBIが配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YUS 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/24 03:27終値2026/05/22 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Ultralife Corporation 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。4 アナリスト機関Joshua SullivanBenchmark CompanyTed KundtzNeedham & CompanyMatthew PaulSidoti & Company, LLC1 その他のアナリストを表示
お知らせ • May 02Ultralife Corporation to Report Q1, 2026 Results on May 08, 2026Ultralife Corporation announced that they will report Q1, 2026 results at 9:30 AM, US Eastern Standard Time on May 08, 2026
お知らせ • Mar 18Ultralife Corporation announced delayed annual 10-K filingOn 03/17/2026, Ultralife Corporation announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Mar 10Ultralife Corporation Reports Unaudited Impairment Results for the Fourth Quarter Ended December 31, 2025Ultralife Corporation reported unaudited impairment results for the fourth quarter ended December 31, 2025. For the period, the company reported intangible asset impairment of $12,181,000. In the quarter of 2025, the company decided to undergo a comprehensive rebranding initiative that consolidated all sub-brands under a singular, unified master brand – Ultralife. To this end, the Accutronics, Southwest Electronic Energy, Excell Battery, McDowell Research and AMTI brands will no longer be used. The Electrochem brand will remain in use, but as a product brand on select primary cells. As a result of the rebranding initiative, the company recorded a $12.2 million non-cash charge to reduce the value of the company’s tradename and trademark intangible assets.
お知らせ • Mar 06Ultralife Corporation to Report Q4, 2025 Results on Mar 10, 2026Ultralife Corporation announced that they will report Q4, 2025 results Pre-Market on Mar 10, 2026
お知らせ • Nov 14Ultralife Corporation to Report Q3, 2025 Results on Nov 18, 2025Ultralife Corporation announced that they will report Q3, 2025 results at 9:30 AM, US Eastern Standard Time on Nov 18, 2025
お知らせ • Nov 08Ultralife Corporation announced delayed 10-Q filingOn 11/07/2025, Ultralife Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
分析記事 • Aug 17Ultralife Corporation's (NASDAQ:ULBI) Share Price Is Still Matching Investor Opinion Despite 25% SlumpNasdaqGM:ULBI 1 Year Share Price vs Fair Value Explore Ultralife's Fair Values from the Community and select yours The...
お知らせ • Jul 29Ultralife Corporation to Report Q2, 2025 Results on Aug 07, 2025Ultralife Corporation announced that they will report Q2, 2025 results Pre-Market on Aug 07, 2025
分析記事 • Jul 02Ultralife (NASDAQ:ULBI) Has A Somewhat Strained Balance SheetHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
お知らせ • Jun 30+ 18 more updatesUltralife Corporation(NasdaqGM:ULBI) dropped from Russell 2000 Growth-Defensive IndexUltralife Corporation(NasdaqGM:ULBI) dropped from Russell 2000 Growth-Defensive Index
Seeking Alpha • Jun 30Ultralife: Recharging Growth With Smart AcquisitionsSummary Ultralife's revenue has been volatile in the past decade or so, but its recent comeback seems to have more legroom to grow. Through a series of recent acquisitions, the company has diversified its revenue dependence on government contracts and obtained access to a more domestic and overseas customer base. Key financial metrics demonstrate strong cash flow and organic integration of its acquisitions, supporting a positive outlook. Intense competition in the industry and integration risk remain, but so far the results show positive impacts in sales and cash flow. In conclusion, ULBI's current price is relatively cheap for interested investors seeking exposure in this field. Read the full article on Seeking Alpha
お知らせ • May 29Ultralife Corporation, Annual General Meeting, Jul 16, 2025Ultralife Corporation, Annual General Meeting, Jul 16, 2025. Location: atlanta airport marriott gateway, 2020 convention center concourse, ga 30337, atlanta United States
お知らせ • Apr 29Ultralife Corporation to Report Q1, 2025 Results on May 09, 2025Ultralife Corporation announced that they will report Q1, 2025 results Pre-Market on May 09, 2025
お知らせ • Mar 09Ultralife Corporation announced delayed annual 10-K filingOn 03/07/2025, Ultralife Corporation announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Feb 26Ultralife Corporation to Report Q4, 2024 Results on Mar 11, 2025Ultralife Corporation announced that they will report Q4, 2024 results Pre-Market on Mar 11, 2025
Seeking Alpha • Jan 22Ultralife Corporation: A High-Risk Stock With Just Enough Upside To HoldSummary Ultralife Corporation is an industrial player with a global presence, specializing in power solutions and communication systems. The company reported a nearly 10% YoY revenue decline in Q3, with contracting profit margins and significant supply chain issues. While Ultralife has a solid balance sheet and liquidity, its thin profit margins and supply chain vulnerabilities raise concerns about long-term shareholder value. Despite its fair valuation, the stock is considered a high-risk play due to weak revenue predictability and operational inefficiencies. The overall recommendation for ULBI is a "hold" rating, as growth prospects exist, but risks outweigh immediate investment opportunities. Read the full article on Seeking Alpha
お知らせ • Jan 06Ultralife Corporation Announces the Appointment of Jeffrey Luke as Chief Marketing Officer and James Pope as Senior Vice President - Sales & Business Development, Battery & Energy Products, Effective January 6, 2025Ultralife Corporation announced the appointment of Jeffrey Luke as Chief Marketing Officer and James Pope as Senior Vice President - Sales & Business Development, Battery & Energy Products, effective January 6, 2025. As Chief Marketing Officer, Jeff will be responsible for reframing corporate and brand strategies, providing alignment and accountability throughout the global organization. He will collaborate closely with sales and engineering teams to develop and execute effective go-to-market strategies, ensuring that Ultralife’s products and solutions meet the evolving needs of customers. Jeff brings over two decades of experience in B2B marketing, including genomics, agriculture, heavy equipment, energy and industrial computing. In his new role, James will focus on expanding reach into both existing and new markets and applications, and on aligning the efforts of global sales and business development teams in pursuing opportunities that maximize revenue, build strategic partnerships, and strengthen presence in competitive markets. He brings over thirty-seven years of experience in the battery and power industry, with a career that spans all major segments of the industry, including cell manufacturing, pack manufacturing, charger development, and work with representative organizations supporting battery and power solutions.
新しいナラティブ • Nov 10Lean Productivity And Tactical Acquisitions Propel Future Growth Amid Industry Challenges Ultralife's focus on cost reduction and productivity improvements is expected to boost net margins significantly.
お知らせ • Oct 24Ultralife Corporation to Report Q3, 2024 Results on Nov 08, 2024Ultralife Corporation announced that they will report Q3, 2024 results Pre-Market on Nov 08, 2024
お知らせ • Oct 01Ultralife Corporation (NasdaqGM:ULBI) signed a stock purchase agreement to acquire Electrochem Solutions, Inc. from Integer Holdings Corporation (NYSE:ITGR) for $50 million.Ultralife Corporation (NasdaqGM:ULBI) signed a stock purchase agreement to acquire Electrochem Solutions, Inc. from Integer Holdings Corporation (NYSE:ITGR) for $50 million on September 30, 2024. A cash consideration of $50 million will be paid by Ultralife Corporation. As part of consideration, $50 million is paid towards common equity of Electrochem Solutions, Inc. Ultralife expects to finance the transaction through its primary lender. The expected completion of the transaction is by the end of October 2024.
分析記事 • Sep 07Should You Think About Buying Ultralife Corporation (NASDAQ:ULBI) Now?While Ultralife Corporation ( NASDAQ:ULBI ) might not have the largest market cap around , it saw significant share...
Seeking Alpha • Aug 03Ultralife: I Bought The Dip; Here Comes The GrowthSummary ULBI's share price fell to $7 following a cyber-attack, but has since recovered to $11.50, making a 50% return in 6 months. ULBI's growth in sales revenue is driven by its battery and energy products segment, with a focus on lithium-ion batteries and communication systems. The company's adoption of lean manufacturing techniques, margin improvement, and debt paydown have led to a significant increase in performance and future cash generation, warranting a Strong Buy recommendation with a price target of $35. Read the full article on Seeking Alpha
分析記事 • Aug 01Ultralife's (NASDAQ:ULBI) Earnings Are Weaker Than They SeemDespite announcing strong earnings, Ultralife Corporation's ( NASDAQ:ULBI ) stock was sluggish. We think that the...
お知らせ • Jul 12Ultralife Corporation to Report Q2, 2024 Results on Jul 25, 2024Ultralife Corporation announced that they will report Q2, 2024 results Pre-Market on Jul 25, 2024
Seeking Alpha • Jun 30Ultralife Corporation Is Attractive HereSummary Ultralife Corporation specializes in batteries for government, military, and private sectors, with a focus on communications systems. Recent growth initiatives include new product developments like EL8000 Case Systems and Thin Cell Batteries. The company has shown strong revenue growth, successful M&A track record, gross margin expansion, and stable operating expenses, making it a promising investment. Read the full article on Seeking Alpha
お知らせ • May 31Ultralife Corporation, Annual General Meeting, Jul 16, 2024Ultralife Corporation, Annual General Meeting, Jul 16, 2024. Location: eastern time at the sheraton charlotte, airport hotel located at 3315, scott futrell drive, nc 28202, charlotte United States
Valuation Update With 7 Day Price Move • May 03Investor sentiment improves as stock rises 17%After last week's 17% share price gain to US$12.56, the stock trades at a trailing P/E ratio of 19.8x. Average trailing P/E is 20x in the Electrical industry in the US. Total returns to shareholders of 60% over the past three years.
Price Target Changed • Apr 28Price target decreased by 7.7% to US$12.00Down from US$13.00, the current price target is provided by 1 analyst. New target price is 5.4% above last closing price of US$11.39. Stock is up 171% over the past year. The company is forecast to post earnings per share of US$0.61 for next year compared to US$0.44 last year.
Reported Earnings • Apr 26First quarter 2024 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2024 results: EPS: US$0.18 (up from US$0.021 loss in 1Q 2023). Revenue: US$41.9m (up 31% from 1Q 2023). Net income: US$2.89m (up US$3.24m from 1Q 2023). Profit margin: 6.9% (up from net loss in 1Q 2023). The move to profitability was driven by higher revenue. Revenue exceeded analyst estimates by 10%. Earnings per share (EPS) also surpassed analyst estimates by 100%. Over the last 3 years on average, earnings per share has increased by 45% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth.
Seeking Alpha • Apr 22Ultralife Corporation: Ready To SurgeSummary ULBI is likely to deliver above-market returns in the next two years, with improving fundamentals and a modest valuation. They should benefit from growth in the battery market and increased military spending. Management is delivering on growth and margin improvement; EPS could double in 2024. With a strengthened balance sheet, they seem poised to start deleveraging rapidly. Read the full article on Seeking Alpha
分析記事 • Apr 16These 4 Measures Indicate That Ultralife (NASDAQ:ULBI) Is Using Debt Reasonably WellThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
お知らせ • Apr 12Ultralife Corporation to Report Q1, 2024 Results on Apr 25, 2024Ultralife Corporation announced that they will report Q1, 2024 results Pre-Market on Apr 25, 2024
Reported Earnings • Mar 23Full year 2023 earnings released: EPS: US$0.44 (vs US$0.007 loss in FY 2022)Full year 2023 results: EPS: US$0.44 (up from US$0.007 loss in FY 2022). Revenue: US$158.6m (up 20% from FY 2022). Net income: US$7.20m (up US$7.32m from FY 2022). Profit margin: 4.5% (up from net loss in FY 2022). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.
分析記事 • Mar 14Slowing Rates Of Return At Ultralife (NASDAQ:ULBI) Leave Little Room For ExcitementIf we want to find a potential multi-bagger, often there are underlying trends that can provide clues. One common...
Reported Earnings • Feb 18Full year 2023 earnings released: EPS: US$0.44 (vs US$0.007 loss in FY 2022)Full year 2023 results: EPS: US$0.44 (up from US$0.007 loss in FY 2022). Revenue: US$158.6m (up 20% from FY 2022). Net income: US$7.20m (up US$7.32m from FY 2022). Profit margin: 4.5% (up from net loss in FY 2022). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Feb 15Investor sentiment improves as stock rises 15%After last week's 15% share price gain to US$7.90, the stock trades at a trailing P/E ratio of 31.5x. Average trailing P/E is 19x in the Electrical industry in the US. Total returns to shareholders of 7.5% over the past three years.
分析記事 • Feb 11Insufficient Growth At Ultralife Corporation (NASDAQ:ULBI) Hampers Share PriceWith a price-to-sales (or "P/S") ratio of 0.9x Ultralife Corporation ( NASDAQ:ULBI ) may be sending bullish signals at...
New Risk • Feb 09New major risk - Revenue and earnings growthEarnings have declined by 59% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. This is currently the only risk that has been identified for the company.
お知らせ • Jan 30Ultralife Corporation to Report Q4, 2023 Results on Feb 15, 2024Ultralife Corporation announced that they will report Q4, 2023 results Pre-Market on Feb 15, 2024
Recent Insider Transactions • Dec 11Independent Chairman recently bought US$111k worth of stockOn the 8th of December, Bradford Whitmore bought around 16k shares on-market at roughly US$6.99 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger purchase worth US$181k. Bradford has been a buyer over the last 12 months, purchasing a net total of US$1.5m worth in shares.
Recent Insider Transactions • Dec 01Independent Chairman recently bought US$181k worth of stockOn the 29th of November, Bradford Whitmore bought around 25k shares on-market at roughly US$7.20 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Bradford has been a buyer over the last 12 months, purchasing a net total of US$1.6m worth in shares.
Recent Insider Transactions • Nov 03Independent Chairman recently bought US$99k worth of stockOn the 1st of November, Bradford Whitmore bought around 14k shares on-market at roughly US$7.14 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger purchase worth US$112k. Bradford has been a buyer over the last 12 months, purchasing a net total of US$1.5m worth in shares.
Valuation Update With 7 Day Price Move • Nov 02Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to US$7.44, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 17x in the Electrical industry in the US. Total returns to shareholders of 45% over the past three years.
Reported Earnings • Oct 26Third quarter 2023 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2023 results: EPS: US$0.082 (up from US$0.015 loss in 3Q 2022). Revenue: US$39.5m (up 19% from 3Q 2022). Net income: US$1.33m (up US$1.57m from 3Q 2022). Profit margin: 3.4% (up from net loss in 3Q 2022). The move to profitability was driven by higher revenue. Revenue is forecast to grow 9.9% p.a. on average during the next 2 years, compared to a 6.6% growth forecast for the Electrical industry in the US. Over the last 3 years on average, earnings per share has fallen by 53% per year but the company’s share price has increased by 12% per year, which means it is well ahead of earnings.
分析記事 • Oct 26Is Now An Opportune Moment To Examine Ultralife Corporation (NASDAQ:ULBI)?While Ultralife Corporation ( NASDAQ:ULBI ) might not be the most widely known stock at the moment, it led the NASDAQGM...
お知らせ • Oct 13Ultralife Corporation to Report Q3, 2023 Results on Oct 26, 2023Ultralife Corporation announced that they will report Q3, 2023 results Pre-Market on Oct 26, 2023
Valuation Update With 7 Day Price Move • Oct 02Investor sentiment improves as stock rises 18%After last week's 18% share price gain to US$11.37, the stock trades at a forward P/E ratio of 24x. Average forward P/E is 21x in the Electrical industry in the US. Total returns to shareholders of 88% over the past three years.
分析記事 • Sep 22Ultralife (NASDAQ:ULBI) May Have Issues Allocating Its CapitalIf you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Recent Insider Transactions • Sep 18Independent Chairman recently bought US$112k worth of stockOn the 15th of September, Bradford Whitmore bought around 11k shares on-market at roughly US$10.15 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Bradford has been a buyer over the last 12 months, purchasing a net total of US$1.4m worth in shares.
Valuation Update With 7 Day Price Move • Aug 22Investor sentiment improves as stock rises 27%After last week's 27% share price gain to US$10.43, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 20x in the Electrical industry in the US. Total returns to shareholders of 64% over the past three years.
Major Estimate Revision • Aug 09Consensus revenue estimates increase by 12%The consensus outlook for revenues in fiscal year 2023 has improved. 2023 revenue forecast increased from US$136.8m to US$153.1m. EPS estimate increased from US$0.21 to US$0.35 per share. Net income forecast to grow 196% next year vs 16% growth forecast for Electrical industry in the US. Consensus price target of US$12.00 unchanged from last update. Share price was steady at US$8.54 over the past week.
New Risk • Jul 29New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of American stocks, typically moving 16% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. This is currently the only risk that has been identified for the company.
Reported Earnings • Jul 28Second quarter 2023 earnings: EPS and revenues exceed analyst expectationsSecond quarter 2023 results: EPS: US$0.21 (up from US$0.032 in 2Q 2022). Revenue: US$42.7m (up 33% from 2Q 2022). Net income: US$3.34m (up US$2.83m from 2Q 2022). Profit margin: 7.8% (up from 1.6% in 2Q 2022). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 33%. Earnings per share (EPS) also surpassed analyst estimates. Revenue is forecast to grow 3.2% p.a. on average during the next 2 years, compared to a 9.0% growth forecast for the Electrical industry in the US. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 84 percentage points per year, which is a significant difference in performance.
お知らせ • Jul 14Ultralife Corporation to Report Q2, 2023 Results on Jul 27, 2023Ultralife Corporation announced that they will report Q2, 2023 results Pre-Market on Jul 27, 2023
Recent Insider Transactions • Jun 18Independent Chairman recently bought US$398k worth of stockOn the 14th of June, Bradford Whitmore bought around 81k shares on-market at roughly US$4.94 per share. This transaction amounted to 1.5% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Bradford has been a buyer over the last 12 months, purchasing a net total of US$1.9m worth in shares.
分析記事 • Jun 08Ultralife (NASDAQ:ULBI) Takes On Some Risk With Its Use Of DebtThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Recent Insider Transactions • Jun 04Independent Chairman recently bought US$146k worth of stockOn the 1st of June, Bradford Whitmore bought around 34k shares on-market at roughly US$4.31 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Bradford has been a buyer over the last 12 months, purchasing a net total of US$1.7m worth in shares.
お知らせ • May 31Ultralife Corporation, Annual General Meeting, Jul 19, 2023Ultralife Corporation, Annual General Meeting, Jul 19, 2023, at 09:00 US Eastern Standard Time. Location: Ultralife Corporation Headquarters located at 2000 Technology Parkway, Newark New York United States Agenda: To consider Election of directors; to consider ratification of the selection of Freed Maxick CPAs, P.C. as company's independent registered public accounting firm for the fiscal year ending December 31, 2023; to consider and vote on a non-binding advisory resolution on executive compensation; to vote on a non-binding advisory resolution on the frequency of future advisory votes on executive compensation; and to consider other matters.
Recent Insider Transactions • May 14Independent Chairman recently bought US$117k worth of stockOn the 11th of May, Bradford Whitmore bought around 29k shares on-market at roughly US$4.06 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger purchase worth US$122k. Bradford has been a buyer over the last 12 months, purchasing a net total of US$1.5m worth in shares.
Reported Earnings • Apr 06Full year 2022 earnings released: US$0.007 loss per share (vs US$0.015 loss in FY 2021)Full year 2022 results: US$0.007 loss per share (improved from US$0.015 loss in FY 2021). Revenue: US$131.8m (up 34% from FY 2021). Net loss: US$119.0k (loss narrowed 49% from FY 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 68 percentage points per year, which is a significant difference in performance.
Recent Insider Transactions • Mar 19Independent Chairman recently bought US$122k worth of stockOn the 13th of March, Bradford Whitmore bought around 30k shares on-market at roughly US$4.06 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Bradford has been a buyer over the last 12 months, purchasing a net total of US$1.4m worth in shares.
Reported Earnings • Mar 03Full year 2022 earnings released: US$0.007 loss per share (vs US$0.015 loss in FY 2021)Full year 2022 results: US$0.007 loss per share (improved from US$0.015 loss in FY 2021). Revenue: US$131.8m (up 34% from FY 2021). Net loss: US$119.0k (loss narrowed 49% from FY 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 67 percentage points per year, which is a significant difference in performance.
Recent Insider Transactions • Dec 12Independent Chairman recently bought US$279k worth of stockOn the 8th of December, Bradford Whitmore bought around 69k shares on-market at roughly US$4.03 per share. This transaction amounted to 1.3% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Bradford has been a buyer over the last 12 months, purchasing a net total of US$1.7m worth in shares.
Price Target Changed • Nov 17Price target increased to US$12.00Up from US$4.50, the current price target is provided by 1 analyst. New target price is 158% above last closing price of US$4.66. Stock is down 23% over the past year. The company is forecast to post earnings per share of US$0.17 next year compared to a net loss per share of US$0.015 last year.
Board Change • Nov 17Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. No experienced directors. 5 highly experienced directors. CEO, President & Director Mike Popielec was the last director to join the board, commencing their role in 2010. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Oct 27Third quarter 2022 earnings: EPS misses analyst expectationsThird quarter 2022 results: US$0.015 loss per share (improved from US$0.036 loss in 3Q 2021). Revenue: US$33.2m (up 53% from 3Q 2021). Net loss: US$239.0k (loss narrowed 59% from 3Q 2021). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates. Revenue is forecast to grow 8.4% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Electrical industry in the US. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 81 percentage points per year, which is a significant difference in performance.
分析記事 • Sep 27Ultralife (NASDAQ:ULBI) Is Carrying A Fair Bit Of DebtSome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Seeking Alpha • Sep 22Ultralife secures $7.5M communications systems contractUltralife (NASDAQ:ULBI) announced Thursday it has received $7.5M contract to supply its integrated system of A-320 amplifiers and A-320HVA radio vehicle mounts to a major international defense contractor for government/defense modernization program. Deliveries are expected to commence in the fourth quarter of 2022 and continue through the first half of 2023. “This contract further demonstrates our success in executing a key element of our revenue growth strategy – the broadening of our global presence with international allies by extending our core U.S. government and defense business,” said Michael D. Popielec, Ultralife’s President and Chief Executive Officer.
Recent Insider Transactions • Aug 21Independent Chairman recently bought US$158k worth of stockOn the 18th of August, Bradford Whitmore bought around 34k shares on-market at roughly US$4.62 per share. In the last 3 months, they made an even bigger purchase worth US$467k. Bradford has been a buyer over the last 12 months, purchasing a net total of US$1.4m worth in shares.
Recent Insider Transactions • Aug 06Independent Chairman recently bought US$467k worth of stockOn the 4th of August, Bradford Whitmore bought around 100k shares on-market at roughly US$4.67 per share. This was the largest purchase by an insider in the last 3 months. Bradford has been a buyer over the last 12 months, purchasing a net total of US$1.2m worth in shares.
Reported Earnings • Jul 28Second quarter 2022 earnings: EPS and revenues exceed analyst expectationsSecond quarter 2022 results: EPS: US$0.032 (down from US$0.051 in 2Q 2021). Revenue: US$32.1m (up 20% from 2Q 2021). Net income: US$512.0k (down 37% from 2Q 2021). Profit margin: 1.6% (down from 3.0% in 2Q 2021). Revenue exceeded analyst estimates by 2.0%. Earnings per share (EPS) also surpassed analyst estimates by 200%. Over the next year, revenue is forecast to grow 24%, compared to a 26% growth forecast for the industry in the US. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 77 percentage points per year, which is a significant difference in performance.
Seeking Alpha • Jul 26Ultralife receives $4.6M communications systems VAA orderUltralife (NASDAQ:ULBI) received a purchase order worth ~$4.6M for supplying its Vehicle Amplifier-Adaptors (VAA) to a global prime defense contractor. Ultralife’s VAA platform provides the soldier with an enhanced range of digital voice and data communications and operational flexibility. Shipments are expected to commence in 2022.
Recent Insider Transactions • Jun 11Independent Chairman recently bought US$219k worth of stockOn the 8th of June, Bradford Whitmore bought around 43k shares on-market at roughly US$5.10 per share. This was the largest purchase by an insider in the last 3 months. Bradford has been a buyer over the last 12 months, purchasing a net total of US$960k worth in shares.
Reported Earnings • Apr 29First quarter 2022 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2022 results: US$0.01 loss per share (down from US$0.042 profit in 1Q 2021). Revenue: US$30.4m (up 17% from 1Q 2021). Net loss: US$168.0k (down 125% from profit in 1Q 2021). Revenue exceeded analyst estimates by 19%. Earnings per share (EPS) also surpassed analyst estimates by 83%. Over the next year, revenue is forecast to grow 24%, compared to a 18% growth forecast for the industry in the US. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 74 percentage points per year, which is a significant difference in performance.
Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. No experienced directors. 5 highly experienced directors. CEO, President & Director Mike Popielec was the last director to join the board, commencing their role in 2010. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
分析記事 • Apr 15Does Ultralife (NASDAQ:ULBI) Have A Healthy Balance Sheet?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Reported Earnings • Mar 11Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2021 results: US$0.015 loss per share (down from US$0.33 profit in FY 2020). Revenue: US$98.3m (down 8.8% from FY 2020). Net loss: US$234.0k (down 105% from profit in FY 2020). Revenue exceeded analyst estimates by 3.4%. Earnings per share (EPS) missed analyst estimates. Over the next year, revenue is forecast to grow 26%, compared to a 21% growth forecast for the industry in the US. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 66 percentage points per year, which is a significant difference in performance.
Recent Insider Transactions • Mar 06Independent Chairman recently bought US$245k worth of stockOn the 28th of February, Bradford Whitmore bought around 55k shares on-market at roughly US$4.45 per share. In the last 3 months, they made an even bigger purchase worth US$297k. Bradford has been a buyer over the last 12 months, purchasing a net total of US$741k worth in shares.
Reported Earnings • Feb 05Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2021 results: US$0.015 loss per share (down from US$0.33 profit in FY 2020). Revenue: US$98.3m (down 8.8% from FY 2020). Net loss: US$234.0k (down 105% from profit in FY 2020). Revenue exceeded analyst estimates by 3.4%. Earnings per share (EPS) missed analyst estimates. Over the next year, revenue is forecast to grow 17%, compared to a 117% growth forecast for the industry in the US. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 67 percentage points per year, which is a significant difference in performance.
Major Estimate Revision • Dec 22Consensus revenue estimates fall by 14%The consensus outlook for revenues in 2021 has deteriorated. 2021 revenue forecast decreased from US$110.7m to US$95.0m. EPS estimate fell from US$0.31 to US$0.02 per share. Net income forecast to grow 134% next year vs 18% growth forecast for Electrical industry in the US. Consensus price target of US$12.00 unchanged from last update. Share price rose 14% to US$6.06 over the past week.
Valuation Update With 7 Day Price Move • Dec 18Investor sentiment improved over the past weekAfter last week's 16% share price gain to US$6.05, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 21x in the Electrical industry in the US. Total loss to shareholders of 6.9% over the past three years.
